Condition: Respiratory Distress Syndrome, Newborn · Premature Birth · Sponsor: Endeavor Health
The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?
This description comes directly from the study's public registry record.
Matthew Derrick, MBBS · 8475702920 · mderrick@northshore.org
Always discuss trial participation with your own doctor first.
| Northshore University Healthsystem | Evanston, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06007547